scispace - formally typeset
A

Alain P. Guerin

Researcher at French Institute of Health and Medical Research

Publications -  86
Citations -  21413

Alain P. Guerin is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Pulse wave velocity & End stage renal disease. The author has an hindex of 56, co-authored 86 publications receiving 20381 citations. Previous affiliations of Alain P. Guerin include John Hunter Hospital.

Papers
More filters
Journal ArticleDOI

Impact of Aortic Stiffness on Survival in End-Stage Renal Disease

TL;DR: These results provide the first direct evidence that in patients with ESRD, increased aortic stiffness determined by measurement of aorta pulse-wave velocity is a strong independent predictor of all-cause and mainly cardiovascular mortality.
Journal ArticleDOI

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality

TL;DR: AMC is a strong prognostic marker of all-cause and CV mortality in HD patients, independently of classical atherogenic factors and the principal effect of AMC on arterial function is increased arterial stiffness.
Journal ArticleDOI

Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'.

TL;DR: In this paper, the authors established reference and normal values for Carotid-femoral pulse wave velocity (PWV), a direct measure of aortic stiffness, based on a large European population.
Journal ArticleDOI

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.

TL;DR: The results of this study showed that the presence and extent of vascular calcifications were strong predictors of cardiovascular and all-cause mortality and carotid incremental elastic modulus gave additional predictive value.
Journal ArticleDOI

Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure

TL;DR: In ESRF patients, the insensitivity of PWV to decreased BP is an independent predictor of mortality and that use of ACE inhibitors has a favorable effect on survival that is independent of BP changes.